Bioworld Technology is an innovative company specialising in manufacturing and marketing antibodies. Bioworld’s current antibodies cover a broad range of cell singling and signalling transductions such as:

•          Chromatin regulation and Acylation signalling
•          MAPK signalling
•          SAPK/JNK signalling
•          Apoptosis and Caspase signalling
•          AKT signalling
•          Transcriptional and translational control
•          PKC signalling
•          Cell cycle and DNA-damage signalling
•          Cytoskeletal signalling